Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jinyinhua Pharyngitis Granules is a Traditional Chinese Medicine (TCM) botanical product developed by the Changchun Traditional Chinese Medicine College for the treatment of acute pharyngitis, specifically the wind-heat pattern. The formulation's primary active component is Jinyinhua (Lonicera japonica, or Honeysuckle), which is traditionally recognized in Chinese medicine for its ability to clear heat and resolve toxicity. The drug is administered orally as granules. It has been evaluated in randomized, double-blind, placebo-controlled clinical trials in China to determine its efficacy in reducing pharyngeal symptoms such as pain, congestion, and inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jinyinhua Pharyngitis Granules.